Teacher Retirement System of Texas lessened its holdings in shares of Maximus, Inc. (NYSE:MMS – Free Report) by 25.4% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 23,017 shares of the health services provider’s stock after selling 7,823 shares during the quarter. Teacher Retirement System of Texas’ holdings in Maximus were worth $1,616,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Fuller & Thaler Asset Management Inc. boosted its position in Maximus by 40.0% during the first quarter. Fuller & Thaler Asset Management Inc. now owns 1,729,305 shares of the health services provider’s stock worth $117,921,000 after purchasing an additional 494,372 shares during the period. Dimensional Fund Advisors LP boosted its position in shares of Maximus by 20.5% in the first quarter. Dimensional Fund Advisors LP now owns 1,695,582 shares of the health services provider’s stock valued at $115,620,000 after acquiring an additional 288,990 shares during the period. Van Berkom & Associates Inc. boosted its position in shares of Maximus by 1.5% in the first quarter. Van Berkom & Associates Inc. now owns 1,275,394 shares of the health services provider’s stock valued at $86,969,000 after acquiring an additional 18,976 shares during the period. AQR Capital Management LLC boosted its position in shares of Maximus by 177.2% in the first quarter. AQR Capital Management LLC now owns 1,173,329 shares of the health services provider’s stock valued at $79,341,000 after acquiring an additional 750,031 shares during the period. Finally, Reinhart Partners LLC. boosted its position in shares of Maximus by 0.3% in the second quarter. Reinhart Partners LLC. now owns 913,856 shares of the health services provider’s stock valued at $64,154,000 after acquiring an additional 2,345 shares during the period. Institutional investors own 97.21% of the company’s stock.
Analysts Set New Price Targets
A number of research firms have recently commented on MMS. Weiss Ratings upgraded shares of Maximus from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, October 8th. Zacks Research lowered shares of Maximus from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 27th. Two analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, Maximus has a consensus rating of “Moderate Buy” and an average target price of $90.00.
Insiders Place Their Bets
In related news, insider Michelle F. Link sold 1,610 shares of the firm’s stock in a transaction that occurred on Wednesday, October 1st. The shares were sold at an average price of $90.86, for a total value of $146,284.60. Following the sale, the insider directly owned 13,508 shares of the company’s stock, valued at $1,227,336.88. This trade represents a 10.65% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 1.60% of the stock is owned by corporate insiders.
Maximus Trading Up 0.5%
Shares of MMS opened at $83.86 on Wednesday. The firm’s 50 day simple moving average is $87.65 and its 200 day simple moving average is $78.36. The company has a market capitalization of $4.73 billion, a P/E ratio of 15.44 and a beta of 0.57. The company has a debt-to-equity ratio of 0.91, a current ratio of 2.27 and a quick ratio of 2.27. Maximus, Inc. has a 1-year low of $63.77 and a 1-year high of $93.73.
Maximus (NYSE:MMS – Get Free Report) last announced its earnings results on Thursday, August 7th. The health services provider reported $2.16 earnings per share for the quarter, beating analysts’ consensus estimates of $1.39 by $0.77. The business had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.29 billion. Maximus had a net margin of 5.83% and a return on equity of 24.44%. Maximus’s quarterly revenue was up 2.5% on a year-over-year basis. During the same period last year, the firm posted $1.74 earnings per share. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. Sell-side analysts forecast that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.
Maximus Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Monday, December 1st. Investors of record on Friday, November 14th will be paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date of this dividend is Friday, November 14th. Maximus’s dividend payout ratio (DPR) is currently 22.10%.
Maximus Profile
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
See Also
- Five stocks we like better than Maximus
- Top Biotech Stocks: Exploring Innovation Opportunities
- 3 Potential Scenarios to Watch for in D-Wave’s Earnings Report
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Eli Lilly Posts Stellar Q3: Long-Term Upside Is Well in Play
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Uber Is Crushing Lyft—And It’s Not Even Close
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.
